nodes	percent_of_prediction	percent_of_DWPC	metapath
Methadone—CHRNA10—ear—pharynx cancer	0.154	0.258	CbGeAlD
Methadone—HTR3A—vagus nerve—pharynx cancer	0.115	0.192	CbGeAlD
Methadone—HTR3A—cranial nerve—pharynx cancer	0.0877	0.147	CbGeAlD
Methadone—CHRNA10—lymphoid tissue—pharynx cancer	0.0286	0.0478	CbGeAlD
Methadone—CHRNA10—head—pharynx cancer	0.023	0.0385	CbGeAlD
Methadone—GRIN3A—head—pharynx cancer	0.0203	0.034	CbGeAlD
Methadone—HTR3A—brainstem—pharynx cancer	0.0193	0.0322	CbGeAlD
Methadone—CYP2D6—Fatty Acid Omega Oxidation—ADH7—pharynx cancer	0.0178	0.0444	CbGpPWpGaD
Methadone—OPRM1—brainstem—pharynx cancer	0.0177	0.0296	CbGeAlD
Methadone—CHRNA10—lymph node—pharynx cancer	0.0161	0.0269	CbGeAlD
Methadone—CYP2D6—Fatty Acid Omega Oxidation—ADH1B—pharynx cancer	0.0156	0.039	CbGpPWpGaD
Methadone—CYP1A2—Fatty Acid Omega Oxidation—ADH7—pharynx cancer	0.0151	0.0377	CbGpPWpGaD
Methadone—CYP2C18—Phase 1 - Functionalization of compounds—ADH7—pharynx cancer	0.0147	0.0366	CbGpPWpGaD
Methadone—OPRD1—head—pharynx cancer	0.0143	0.024	CbGeAlD
Methadone—OPRK1—head—pharynx cancer	0.0137	0.023	CbGeAlD
Methadone—CYP1A2—Fatty Acid Omega Oxidation—ADH1B—pharynx cancer	0.0133	0.033	CbGpPWpGaD
Methadone—CYP2C18—Phase 1 - Functionalization of compounds—ADH1B—pharynx cancer	0.0129	0.0321	CbGpPWpGaD
Methadone—CYP3A4—Fatty Acid Omega Oxidation—ADH7—pharynx cancer	0.0117	0.0291	CbGpPWpGaD
Methadone—CYP19A1—Phase 1 - Functionalization of compounds—ADH7—pharynx cancer	0.0113	0.028	CbGpPWpGaD
Methadone—OPRM1—spinal cord—pharynx cancer	0.011	0.0184	CbGeAlD
Methadone—HTR3A—head—pharynx cancer	0.0107	0.0178	CbGeAlD
Methadone—CYP3A4—Fatty Acid Omega Oxidation—ADH1B—pharynx cancer	0.0102	0.0255	CbGpPWpGaD
Methadone—CYP19A1—Phase 1 - Functionalization of compounds—ADH1B—pharynx cancer	0.00987	0.0246	CbGpPWpGaD
Methadone—OPRM1—head—pharynx cancer	0.00978	0.0163	CbGeAlD
Methadone—CYP3A7—Phase 1 - Functionalization of compounds—ADH7—pharynx cancer	0.00978	0.0244	CbGpPWpGaD
Methadone—CYP2C18—Biological oxidations—CNDP2—pharynx cancer	0.00864	0.0215	CbGpPWpGaD
Methadone—CYP3A7—Phase 1 - Functionalization of compounds—ADH1B—pharynx cancer	0.00857	0.0214	CbGpPWpGaD
Methadone—CYP19A1—head—pharynx cancer	0.00821	0.0137	CbGeAlD
Methadone—CYP2C18—Biological oxidations—ADH7—pharynx cancer	0.00781	0.0195	CbGpPWpGaD
Methadone—CYP2B6—Phase 1 - Functionalization of compounds—ADH7—pharynx cancer	0.00723	0.018	CbGpPWpGaD
Methadone—CYP2D6—brainstem—pharynx cancer	0.00709	0.0119	CbGeAlD
Methadone—CYP3A5—Phase 1 - Functionalization of compounds—ADH7—pharynx cancer	0.00707	0.0176	CbGpPWpGaD
Methadone—CYP2C18—Biological oxidations—ADH1B—pharynx cancer	0.00685	0.0171	CbGpPWpGaD
Methadone—CYP19A1—Biological oxidations—CNDP2—pharynx cancer	0.00661	0.0165	CbGpPWpGaD
Methadone—CYP2B6—lymphoid tissue—pharynx cancer	0.00655	0.0109	CbGeAlD
Methadone—CYP2B6—Phase 1 - Functionalization of compounds—ADH1B—pharynx cancer	0.00634	0.0158	CbGpPWpGaD
Methadone—CYP3A5—Phase 1 - Functionalization of compounds—ADH1B—pharynx cancer	0.0062	0.0154	CbGpPWpGaD
Methadone—CYP2C8—Phase 1 - Functionalization of compounds—ADH7—pharynx cancer	0.00612	0.0152	CbGpPWpGaD
Methadone—CYP19A1—Biological oxidations—ADH7—pharynx cancer	0.00598	0.0149	CbGpPWpGaD
Methadone—CYP19A1—lymph node—pharynx cancer	0.00575	0.00961	CbGeAlD
Methadone—CYP3A7—Biological oxidations—CNDP2—pharynx cancer	0.00574	0.0143	CbGpPWpGaD
Methadone—CYP2C19—Phase 1 - Functionalization of compounds—ADH7—pharynx cancer	0.00546	0.0136	CbGpPWpGaD
Methadone—CYP2C8—Phase 1 - Functionalization of compounds—ADH1B—pharynx cancer	0.00537	0.0134	CbGpPWpGaD
Methadone—CYP2B6—head—pharynx cancer	0.00528	0.00881	CbGeAlD
Methadone—CYP19A1—Biological oxidations—ADH1B—pharynx cancer	0.00524	0.0131	CbGpPWpGaD
Methadone—CYP3A7—Biological oxidations—ADH7—pharynx cancer	0.00519	0.0129	CbGpPWpGaD
Methadone—CYP2D6—Phase 1 - Functionalization of compounds—ADH7—pharynx cancer	0.00502	0.0125	CbGpPWpGaD
Methadone—CYP2C9—Phase 1 - Functionalization of compounds—ADH7—pharynx cancer	0.00498	0.0124	CbGpPWpGaD
Methadone—CYP2C19—Phase 1 - Functionalization of compounds—ADH1B—pharynx cancer	0.00479	0.0119	CbGpPWpGaD
Methadone—CYP3A7—Biological oxidations—ADH1B—pharynx cancer	0.00455	0.0113	CbGpPWpGaD
Methadone—ABCB1—epithelium—pharynx cancer	0.00454	0.00759	CbGeAlD
Methadone—CYP2D6—Phase 1 - Functionalization of compounds—ADH1B—pharynx cancer	0.00441	0.011	CbGpPWpGaD
Methadone—CYP2C9—Phase 1 - Functionalization of compounds—ADH1B—pharynx cancer	0.00437	0.0109	CbGpPWpGaD
Methadone—CYP1A2—Phase II conjugation—CNDP2—pharynx cancer	0.00427	0.0106	CbGpPWpGaD
Methadone—CYP1A2—Phase 1 - Functionalization of compounds—ADH7—pharynx cancer	0.00426	0.0106	CbGpPWpGaD
Methadone—CYP2B6—Biological oxidations—CNDP2—pharynx cancer	0.00425	0.0106	CbGpPWpGaD
Methadone—CYP3A5—Biological oxidations—CNDP2—pharynx cancer	0.00415	0.0103	CbGpPWpGaD
Methadone—ABCB1—trachea—pharynx cancer	0.00402	0.00671	CbGeAlD
Methadone—CYP2D6—head—pharynx cancer	0.00392	0.00655	CbGeAlD
Methadone—CYP2B6—Biological oxidations—ADH7—pharynx cancer	0.00384	0.00957	CbGpPWpGaD
Methadone—CYP3A5—Biological oxidations—ADH7—pharynx cancer	0.00375	0.00935	CbGpPWpGaD
Methadone—CYP1A2—Phase 1 - Functionalization of compounds—ADH1B—pharynx cancer	0.00373	0.0093	CbGpPWpGaD
Methadone—CYP2C8—Biological oxidations—CNDP2—pharynx cancer	0.0036	0.00895	CbGpPWpGaD
Methadone—ABCB1—lymphoid tissue—pharynx cancer	0.0035	0.00585	CbGeAlD
Methadone—CYP2B6—Biological oxidations—ADH1B—pharynx cancer	0.00337	0.00839	CbGpPWpGaD
Methadone—CYP3A5—Biological oxidations—ADH1B—pharynx cancer	0.00329	0.0082	CbGpPWpGaD
Methadone—CYP3A4—Phase 1 - Functionalization of compounds—ADH7—pharynx cancer	0.00329	0.00818	CbGpPWpGaD
Methadone—CYP2C8—Biological oxidations—ADH7—pharynx cancer	0.00325	0.0081	CbGpPWpGaD
Methadone—CYP2C19—Biological oxidations—CNDP2—pharynx cancer	0.00321	0.00799	CbGpPWpGaD
Methadone—ABCB1—spinal cord—pharynx cancer	0.00317	0.0053	CbGeAlD
Methadone—CYP2D6—Biological oxidations—CNDP2—pharynx cancer	0.00295	0.00735	CbGpPWpGaD
Methadone—CYP2C9—Biological oxidations—CNDP2—pharynx cancer	0.00293	0.00729	CbGpPWpGaD
Methadone—CYP2C19—Biological oxidations—ADH7—pharynx cancer	0.0029	0.00723	CbGpPWpGaD
Methadone—CYP3A4—Phase 1 - Functionalization of compounds—ADH1B—pharynx cancer	0.00288	0.00718	CbGpPWpGaD
Methadone—CYP2C8—Biological oxidations—ADH1B—pharynx cancer	0.00285	0.0071	CbGpPWpGaD
Methadone—ABCB1—head—pharynx cancer	0.00282	0.00471	CbGeAlD
Methadone—CYP2D6—Biological oxidations—ADH7—pharynx cancer	0.00267	0.00665	CbGpPWpGaD
Methadone—CYP2C9—Biological oxidations—ADH7—pharynx cancer	0.00265	0.00659	CbGpPWpGaD
Methadone—CYP2C19—Biological oxidations—ADH1B—pharynx cancer	0.00254	0.00634	CbGpPWpGaD
Methadone—CYP1A2—Biological oxidations—CNDP2—pharynx cancer	0.0025	0.00623	CbGpPWpGaD
Methadone—CYP2D6—Biological oxidations—ADH1B—pharynx cancer	0.00234	0.00583	CbGpPWpGaD
Methadone—CYP2C9—Biological oxidations—ADH1B—pharynx cancer	0.00232	0.00578	CbGpPWpGaD
Methadone—CYP1A2—Biological oxidations—ADH7—pharynx cancer	0.00226	0.00563	CbGpPWpGaD
Methadone—CYP1A2—Biological oxidations—ADH1B—pharynx cancer	0.00198	0.00494	CbGpPWpGaD
Methadone—ABCB1—lymph node—pharynx cancer	0.00197	0.0033	CbGeAlD
Methadone—CYP3A4—Biological oxidations—CNDP2—pharynx cancer	0.00193	0.00481	CbGpPWpGaD
Methadone—CYP3A4—Biological oxidations—ADH7—pharynx cancer	0.00175	0.00435	CbGpPWpGaD
Methadone—CYP19A1—Integrated Breast Cancer Pathway—CDH1—pharynx cancer	0.0017	0.00423	CbGpPWpGaD
Methadone—CYP3A4—Biological oxidations—ADH1B—pharynx cancer	0.00153	0.00381	CbGpPWpGaD
Methadone—CYP2C18—Metabolism—CNDP2—pharynx cancer	0.00148	0.00368	CbGpPWpGaD
Methadone—CYP2C18—Metabolism—ADH7—pharynx cancer	0.00134	0.00333	CbGpPWpGaD
Methadone—CYP19A1—Integrated Breast Cancer Pathway—CCND1—pharynx cancer	0.00127	0.00315	CbGpPWpGaD
Methadone—CYP2C18—Metabolism—ADH1B—pharynx cancer	0.00117	0.00292	CbGpPWpGaD
Methadone—CYP19A1—Metabolism—CNDP2—pharynx cancer	0.00113	0.00282	CbGpPWpGaD
Methadone—CYP2C18—Metabolism—B4GALT5—pharynx cancer	0.00112	0.00279	CbGpPWpGaD
Methadone—CYP19A1—Metabolism—ADH7—pharynx cancer	0.00102	0.00255	CbGpPWpGaD
Methadone—CYP19A1—Integrated Breast Cancer Pathway—EGFR—pharynx cancer	0.000993	0.00247	CbGpPWpGaD
Methadone—CYP3A7—Metabolism—CNDP2—pharynx cancer	0.000982	0.00245	CbGpPWpGaD
Methadone—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—pharynx cancer	0.000971	0.00242	CbGpPWpGaD
Methadone—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—pharynx cancer	0.000971	0.00242	CbGpPWpGaD
Methadone—CYP19A1—Metabolism—ADH1B—pharynx cancer	0.000897	0.00223	CbGpPWpGaD
Methadone—CYP3A7—Metabolism—ADH7—pharynx cancer	0.000888	0.00221	CbGpPWpGaD
Methadone—CYP19A1—Metabolism—B4GALT5—pharynx cancer	0.000857	0.00213	CbGpPWpGaD
Methadone—CYP19A1—Integrated Breast Cancer Pathway—TP53—pharynx cancer	0.000834	0.00208	CbGpPWpGaD
Methadone—CYP3A7—Metabolism—ADH1B—pharynx cancer	0.000779	0.00194	CbGpPWpGaD
Methadone—CYP3A7—Metabolism—B4GALT5—pharynx cancer	0.000744	0.00185	CbGpPWpGaD
Methadone—CYP2B6—Metabolism—CNDP2—pharynx cancer	0.000726	0.00181	CbGpPWpGaD
Methadone—CYP3A5—Metabolism—CNDP2—pharynx cancer	0.00071	0.00177	CbGpPWpGaD
Methadone—CYP2B6—Metabolism—ADH7—pharynx cancer	0.000657	0.00164	CbGpPWpGaD
Methadone—CYP3A5—Metabolism—ADH7—pharynx cancer	0.000642	0.0016	CbGpPWpGaD
Methadone—CYP2C8—Metabolism—CNDP2—pharynx cancer	0.000615	0.00153	CbGpPWpGaD
Methadone—CYP2B6—Metabolism—ADH1B—pharynx cancer	0.000576	0.00143	CbGpPWpGaD
Methadone—CYP3A5—Metabolism—ADH1B—pharynx cancer	0.000563	0.0014	CbGpPWpGaD
Methadone—CYP2C8—Metabolism—ADH7—pharynx cancer	0.000556	0.00138	CbGpPWpGaD
Methadone—CYP2B6—Metabolism—B4GALT5—pharynx cancer	0.00055	0.00137	CbGpPWpGaD
Methadone—CYP2C19—Metabolism—CNDP2—pharynx cancer	0.000549	0.00137	CbGpPWpGaD
Methadone—CYP3A5—Metabolism—B4GALT5—pharynx cancer	0.000538	0.00134	CbGpPWpGaD
Methadone—ABCB1—Metabolism—CNDP2—pharynx cancer	0.000536	0.00133	CbGpPWpGaD
Methadone—CYP2D6—Metabolism—CNDP2—pharynx cancer	0.000505	0.00126	CbGpPWpGaD
Methadone—CYP2C9—Metabolism—CNDP2—pharynx cancer	0.0005	0.00125	CbGpPWpGaD
Methadone—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—pharynx cancer	0.000497	0.00124	CbGpPWpGaD
Methadone—CYP2C19—Metabolism—ADH7—pharynx cancer	0.000496	0.00124	CbGpPWpGaD
Methadone—CYP2C8—Metabolism—ADH1B—pharynx cancer	0.000488	0.00121	CbGpPWpGaD
Methadone—ABCB1—Metabolism—ADH7—pharynx cancer	0.000484	0.00121	CbGpPWpGaD
Methadone—CYP2C8—Metabolism—B4GALT5—pharynx cancer	0.000466	0.00116	CbGpPWpGaD
Methadone—CYP2D6—Metabolism—ADH7—pharynx cancer	0.000456	0.00114	CbGpPWpGaD
Methadone—CYP2C9—Metabolism—ADH7—pharynx cancer	0.000453	0.00113	CbGpPWpGaD
Methadone—CYP2C19—Metabolism—ADH1B—pharynx cancer	0.000435	0.00108	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—CNDP2—pharynx cancer	0.000428	0.00107	CbGpPWpGaD
Methadone—ABCB1—Metabolism—ADH1B—pharynx cancer	0.000425	0.00106	CbGpPWpGaD
Methadone—CYP2C19—Metabolism—B4GALT5—pharynx cancer	0.000416	0.00104	CbGpPWpGaD
Methadone—ABCB1—Metabolism—B4GALT5—pharynx cancer	0.000406	0.00101	CbGpPWpGaD
Methadone—CYP2D6—Metabolism—ADH1B—pharynx cancer	0.0004	0.000997	CbGpPWpGaD
Methadone—CYP2C9—Metabolism—ADH1B—pharynx cancer	0.000397	0.000988	CbGpPWpGaD
Methadone—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—pharynx cancer	0.00039	0.000971	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—ADH7—pharynx cancer	0.000387	0.000963	CbGpPWpGaD
Methadone—CYP2D6—Metabolism—B4GALT5—pharynx cancer	0.000383	0.000953	CbGpPWpGaD
Methadone—CYP2C9—Metabolism—B4GALT5—pharynx cancer	0.000379	0.000945	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—ADH1B—pharynx cancer	0.000339	0.000845	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—CNDP2—pharynx cancer	0.00033	0.000822	CbGpPWpGaD
Methadone—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—pharynx cancer	0.000327	0.000815	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—B4GALT5—pharynx cancer	0.000324	0.000807	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—ADH7—pharynx cancer	0.000298	0.000743	CbGpPWpGaD
Methadone—OPRD1—Signaling by GPCR—EGFR—pharynx cancer	0.000295	0.000735	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—ADH1B—pharynx cancer	0.000262	0.000652	CbGpPWpGaD
Methadone—OPRK1—Signaling by GPCR—EGFR—pharynx cancer	0.000259	0.000644	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—B4GALT5—pharynx cancer	0.00025	0.000623	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—CCND1—pharynx cancer	0.000222	0.000553	CbGpPWpGaD
Methadone—OPRM1—Signaling by GPCR—EGFR—pharynx cancer	0.000219	0.000545	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—CCND1—pharynx cancer	0.000195	0.000485	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—EGFR—pharynx cancer	0.000174	0.000434	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—CCND1—pharynx cancer	0.000165	0.00041	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—EGFR—pharynx cancer	0.000153	0.000381	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—TP53—pharynx cancer	0.000146	0.000364	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—EGFR—pharynx cancer	0.000129	0.000322	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—TP53—pharynx cancer	0.000128	0.00032	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—TP53—pharynx cancer	0.000108	0.00027	CbGpPWpGaD
